| ■ 영문 제목 : Global Ophthalmology Therapeutics Market 2023-2027
|
 | ■ 상품코드 : IRTNTR40882-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2022년 12월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 북미, 유럽, 아시아, 기타 지역
■ 산업 분야 : 의약품
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1명 열람용) | USD2,500 ⇒환산￦3,500,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산￦5,600,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
테크나비오 조사회사는 세계의 안과 치료제 시장 규모가 2022년부터 2027년까지 연평균 6.25% 성장하여, 157.2억 달러에 달할 것으로 예측하고 있습니다. 본 조사 보고서는 세계의 안과 치료제 시장을 조사 대상으로 하여, 개요, 시장 현황, 시장 규모 예측, 과거 시장 규모, 파이브 포스 분석, 제품별(망막 질환, 녹내장, 안구 건조증, 눈 감염증 및 염증, 기타) 분석, 종류별 (처방약, 일반 의약품) 분석, 고객 현황, 지역별 현황 (북미, 유럽, 아시아, 기타 지역, 미국, 독일, 영국, 프랑스, 일본) 분석, 추진 요인/과제/동향, 기업 현황, 기업 분석 등의 항목을 게재하고 있습니다. 또한 본 자료는 AbbVie Inc., Adrif Vision, Aldeyra Therapeutics Inc., Bausch Health Co Inc., Bayer AG, Eyeris Vision Care Pvt. Ltd., F. Hoffmann La Roche Ltd., Grevis Pharmaceuticals Pvt. Ltd., Novartis AG, Ocular Therapeutix Inc., Otsuka Pharmaceutical Co. Ltd., Oxurion NV, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santan Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Swissvision, Teva Pharmaceutical Ltd., Vee Remedies, Visufarma 등의 기업 정보를 포함하고 있습니다.
・개요
・시장 현황
・시장 규모 예측
・과거 시장 규모
・파이브 포스 분석
・세계의 안과 치료제 시장 규모 : 제품별
- 망막 질환 치료제의 시장 규모
- 녹내장 치료제의 시장 규모
- 안구 건조증 치료제의 시장 규모
- 눈 감염증 및 염증 치료제의 시장 규모
- 기타 제품의 시장 규모
・세계의 안과 치료제 시장 규모 : 종류별
- 처방약 시장 규모
- 일반 의약품 시장 규모
・고객 현황
・세계의 안과 치료제 시장 규모 : 지역별
- 북미의 안과 치료제 시장 규모
- 유럽의 안과 치료제 시장 규모
- 아시아의 안과 치료제 시장 규모
- 기타 지역의 안과 치료제 시장 규모
- 미국의 안과 치료제 시장 규모
- 독일의 안과 치료제 시장 규모
- 영국의 안과 치료제 시장 규모
- 프랑스의 안과 치료제 시장 규모
- 일본의 안과 치료제 시장 규모
・추진 요인/과제/동향
・기업 현황
・기업 분석
테크나비오사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 테크나비오사의 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
■ 보고서 개요Technavio Announces the Publication of its Research Report – Global Ophthalmology Therapeutics Market 2023-2027Technavio recognizes the following companies as the key players in the global ophthalmology therapeutics market: AbbVie Inc., Adrif Vision, Aldeyra Therapeutics Inc., Bausch Health Co Inc., Bayer AG, Eyeris Vision Care Pvt. Ltd., F. Hoffmann La Roche Ltd., Grevis Pharmaceuticals Pvt. Ltd., Novartis AG, Ocular Therapeutix Inc., Otsuka Pharmaceutical Co. Ltd., Oxurion NV, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Swissvision, Teva Pharmaceutical Industries Ltd., Vee Remedies, and Visufarma.
Commenting on the report, an analyst from Technavio said: “The latest trend gaining momentum in the market is development of novel drug delivery systems.”
According to the report, one of the major drivers for this market is the increase in the prevalence of eye diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit- www.technavio.com/report/ophthalmology-therapeutics-market-industry-analysis
Technavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit- www.technavio.com/industries/pharmaceuticals
Follow us on Twitter @Technavio
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global ophthalmology therapeutics market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global ophthalmology therapeutics market 2017 – 2021 ($ billion)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ billion)
o 4.3 Type Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Type Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Retinal disorder therapeutics – Market size and forecast 2022-2027
o Exhibit 34: Chart on Retinal disorder therapeutics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Retinal disorder therapeutics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Retinal disorder therapeutics – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Retinal disorder therapeutics – Year-over-year growth 2022-2027 (%)
o 6.4 Glaucoma therapeutics – Market size and forecast 2022-2027
o Exhibit 38: Chart on Glaucoma therapeutics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Glaucoma therapeutics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Glaucoma therapeutics – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Glaucoma therapeutics – Year-over-year growth 2022-2027 (%)
o 6.5 Dry eye disease therapeutics – Market size and forecast 2022-2027
o Exhibit 42: Chart on Dry eye disease therapeutics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Dry eye disease therapeutics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Dry eye disease therapeutics – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Dry eye disease therapeutics – Year-over-year growth 2022-2027 (%)
o 6.6 Eye infections and inflammation therapeutics – Market size and forecast 2022-2027
o Exhibit 46: Chart on Eye infections and inflammation therapeutics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 47: Data Table on Eye infections and inflammation therapeutics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Chart on Eye infections and inflammation therapeutics – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Eye infections and inflammation therapeutics – Year-over-year growth 2022-2027 (%)
o 6.7 Other therapeutics – Market size and forecast 2022-2027
o Exhibit 50: Chart on Other therapeutics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 51: Data Table on Other therapeutics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Chart on Other therapeutics – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Other therapeutics – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Product
o Exhibit 54: Market opportunity by Product ($ billion)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 55: Chart on Type – Market share 2022-2027 (%)
o Exhibit 56: Data Table on Type – Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 57: Chart on Comparison by Type
o Exhibit 58: Data Table on Comparison by Type
o 7.3 Prescription drugs – Market size and forecast 2022-2027
o Exhibit 59: Chart on Prescription drugs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 60: Data Table on Prescription drugs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Chart on Prescription drugs – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Prescription drugs – Year-over-year growth 2022-2027 (%)
o 7.4 OTC drugs – Market size and forecast 2022-2027
o Exhibit 63: Chart on OTC drugs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 64: Data Table on OTC drugs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Chart on OTC drugs – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on OTC drugs – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Type
o Exhibit 67: Market opportunity by Type ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 71: Chart on Geographic comparison
o Exhibit 72: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 73: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 75: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 77: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 78: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 79: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 81: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 82: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 83: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 85: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 86: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 87: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 89: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 90: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 91: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 93: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 94: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 95: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 97: Chart on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 98: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 99: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 France – Market size and forecast 2022-2027
o Exhibit 101: Chart on France – Market size and forecast 2022-2027 ($ billion)
o Exhibit 102: Data Table on France – Market size and forecast 2022-2027 ($ billion)
o Exhibit 103: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 105: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 106: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 107: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 109: Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 110: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 112: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 113: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 114: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 115: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 116: AbbVie Inc. – Overview
o Exhibit 117: AbbVie Inc. – Product / Service
o Exhibit 118: AbbVie Inc. – Key news
o Exhibit 119: AbbVie Inc. – Key offerings
o 12.4 Aldeyra Therapeutics Inc.
o Exhibit 120: Aldeyra Therapeutics Inc. – Overview
o Exhibit 121: Aldeyra Therapeutics Inc. – Product / Service
o Exhibit 122: Aldeyra Therapeutics Inc. – Key offerings
o 12.5 Bausch Health Co Inc.
o Exhibit 123: Bausch Health Co Inc. – Overview
o Exhibit 124: Bausch Health Co Inc. – Business segments
o Exhibit 125: Bausch Health Co Inc. – Key news
o Exhibit 126: Bausch Health Co Inc. – Key offerings
o Exhibit 127: Bausch Health Co Inc. – Segment focus
o 12.6 Bayer AG
o Exhibit 128: Bayer AG – Overview
o Exhibit 129: Bayer AG – Business segments
o Exhibit 130: Bayer AG – Key news
o Exhibit 131: Bayer AG – Key offerings
o Exhibit 132: Bayer AG – Segment focus
o 12.7 F. Hoffmann La Roche Ltd.
o Exhibit 133: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 134: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 135: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 136: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 137: F. Hoffmann La Roche Ltd. – Segment focus
o 12.8 Novartis AG
o Exhibit 138: Novartis AG – Overview
o Exhibit 139: Novartis AG – Business segments
o Exhibit 140: Novartis AG – Key offerings
o Exhibit 141: Novartis AG – Segment focus
o 12.9 Ocular Therapeutix Inc.
o Exhibit 142: Ocular Therapeutix Inc. – Overview
o Exhibit 143: Ocular Therapeutix Inc. – Product / Service
o Exhibit 144: Ocular Therapeutix Inc. – Key offerings
o 12.10 Otsuka Pharmaceutical Co. Ltd.
o Exhibit 145: Otsuka Pharmaceutical Co. Ltd. – Overview
o Exhibit 146: Otsuka Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 147: Otsuka Pharmaceutical Co. Ltd. – Key offerings
o 12.11 Oxurion NV
o Exhibit 148: Oxurion NV – Overview
o Exhibit 149: Oxurion NV – Product / Service
o Exhibit 150: Oxurion NV – Key offerings
o 12.12 Pfizer Inc.
o Exhibit 151: Pfizer Inc. – Overview
o Exhibit 152: Pfizer Inc. – Product / Service
o Exhibit 153: Pfizer Inc. – Key news
o Exhibit 154: Pfizer Inc. – Key offerings
o 12.13 Regeneron Pharmaceuticals Inc.
o Exhibit 155: Regeneron Pharmaceuticals Inc. – Overview
o Exhibit 156: Regeneron Pharmaceuticals Inc. – Product / Service
o Exhibit 157: Regeneron Pharmaceuticals Inc. – Key offerings
o 12.14 Santen Pharmaceutical Co. Ltd.
o Exhibit 158: Santen Pharmaceutical Co. Ltd. – Overview
o Exhibit 159: Santen Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 160: Santen Pharmaceutical Co. Ltd. – Key offerings
o 12.15 Sun Pharmaceutical Industries Ltd.
o Exhibit 161: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 162: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 163: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 164: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 165: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 166: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 167: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 168: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Visufarma
o Exhibit 169: Visufarma – Overview
o Exhibit 170: Visufarma – Product / Service
o Exhibit 171: Visufarma – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 172: Inclusions checklist
o Exhibit 173: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 174: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 175: Research methodology
o Exhibit 176: Validation techniques employed for market sizing
o Exhibit 177: Information sources
o 13.5 List of abbreviations
o Exhibit 178: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global ophthalmology therapeutics market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – Type Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Retinal disorder therapeutics – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Retinal disorder therapeutics – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Retinal disorder therapeutics – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Retinal disorder therapeutics – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Glaucoma therapeutics – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Glaucoma therapeutics – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Glaucoma therapeutics – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Glaucoma therapeutics – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Dry eye disease therapeutics – Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Dry eye disease therapeutics – Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Dry eye disease therapeutics – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Dry eye disease therapeutics – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Eye infections and inflammation therapeutics – Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on Eye infections and inflammation therapeutics – Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on Eye infections and inflammation therapeutics – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Eye infections and inflammation therapeutics – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Other therapeutics – Market size and forecast 2022-2027 ($ billion)
Exhibits51: Data Table on Other therapeutics – Market size and forecast 2022-2027 ($ billion)
Exhibits52: Chart on Other therapeutics – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Other therapeutics – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Product ($ billion)
Exhibits55: Chart on Type – Market share 2022-2027 (%)
Exhibits56: Data Table on Type – Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by Type
Exhibits58: Data Table on Comparison by Type
Exhibits59: Chart on Prescription drugs – Market size and forecast 2022-2027 ($ billion)
Exhibits60: Data Table on Prescription drugs – Market size and forecast 2022-2027 ($ billion)
Exhibits61: Chart on Prescription drugs – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Prescription drugs – Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on OTC drugs – Market size and forecast 2022-2027 ($ billion)
Exhibits64: Data Table on OTC drugs – Market size and forecast 2022-2027 ($ billion)
Exhibits65: Chart on OTC drugs – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on OTC drugs – Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Type ($ billion)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits74: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits75: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits78: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits79: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits82: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits83: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits86: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits87: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits90: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits91: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits94: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits95: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits98: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits99: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on France – Market size and forecast 2022-2027 ($ billion)
Exhibits102: Data Table on France – Market size and forecast 2022-2027 ($ billion)
Exhibits103: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits106: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits107: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ billion)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: AbbVie Inc. – Overview
Exhibits117: AbbVie Inc. – Product / Service
Exhibits118: AbbVie Inc. – Key news
Exhibits119: AbbVie Inc. – Key offerings
Exhibits120: Aldeyra Therapeutics Inc. – Overview
Exhibits121: Aldeyra Therapeutics Inc. – Product / Service
Exhibits122: Aldeyra Therapeutics Inc. – Key offerings
Exhibits123: Bausch Health Co Inc. – Overview
Exhibits124: Bausch Health Co Inc. – Business segments
Exhibits125: Bausch Health Co Inc. – Key news
Exhibits126: Bausch Health Co Inc. – Key offerings
Exhibits127: Bausch Health Co Inc. – Segment focus
Exhibits128: Bayer AG – Overview
Exhibits129: Bayer AG – Business segments
Exhibits130: Bayer AG – Key news
Exhibits131: Bayer AG – Key offerings
Exhibits132: Bayer AG – Segment focus
Exhibits133: F. Hoffmann La Roche Ltd. – Overview
Exhibits134: F. Hoffmann La Roche Ltd. – Business segments
Exhibits135: F. Hoffmann La Roche Ltd. – Key news
Exhibits136: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits137: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits138: Novartis AG – Overview
Exhibits139: Novartis AG – Business segments
Exhibits140: Novartis AG – Key offerings
Exhibits141: Novartis AG – Segment focus
Exhibits142: Ocular Therapeutix Inc. – Overview
Exhibits143: Ocular Therapeutix Inc. – Product / Service
Exhibits144: Ocular Therapeutix Inc. – Key offerings
Exhibits145: Otsuka Pharmaceutical Co. Ltd. – Overview
Exhibits146: Otsuka Pharmaceutical Co. Ltd. – Product / Service
Exhibits147: Otsuka Pharmaceutical Co. Ltd. – Key offerings
Exhibits148: Oxurion NV – Overview
Exhibits149: Oxurion NV – Product / Service
Exhibits150: Oxurion NV – Key offerings
Exhibits151: Pfizer Inc. – Overview
Exhibits152: Pfizer Inc. – Product / Service
Exhibits153: Pfizer Inc. – Key news
Exhibits154: Pfizer Inc. – Key offerings
Exhibits155: Regeneron Pharmaceuticals Inc. – Overview
Exhibits156: Regeneron Pharmaceuticals Inc. – Product / Service
Exhibits157: Regeneron Pharmaceuticals Inc. – Key offerings
Exhibits158: Santen Pharmaceutical Co. Ltd. – Overview
Exhibits159: Santen Pharmaceutical Co. Ltd. – Product / Service
Exhibits160: Santen Pharmaceutical Co. Ltd. – Key offerings
Exhibits161: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits162: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits163: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits164: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits165: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits166: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits167: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits168: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits169: Visufarma – Overview
Exhibits170: Visufarma – Product / Service
Exhibits171: Visufarma – Key offerings
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Validation techniques employed for market sizing
Exhibits177: Information sources
Exhibits178: List of abbreviations
|
| ※본 조사보고서 [세계의 안과 치료제 시장 (2023년~2027년)] (코드 : IRTNTR40882-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 안과 치료제 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요! 세계의 안과 치료제 시장 (2023년~2027년)
